Cargando…

NH(2)-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: The role of tumor necrosis factor-α

OBJECTIVE: Circulating levels of NH(2)-terminal probrain natriuretic peptide (NT-proBNP), a marker of acute heart failure, are associated with increased risk of cardiovascular disease (CVD) in the general population. However, there is little information on the potential role of NT-proBNP as a biomar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruden, Gabriella, Barutta, Federica, Chaturvedi, Nish, Schalkwijk, Casper, Stehouwer, Coen D., Pinach, Silvia, Manzo, Maria, Loiacono, Maria, Tricarico, Marinella, Mengozzi, Giulio, Witte, Daniel R., Fuller, John H., Perin, Paolo Cavallo, Bruno, Graziella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425012/ https://www.ncbi.nlm.nih.gov/pubmed/22699286 http://dx.doi.org/10.2337/dc12-0089

Ejemplares similares

Anti–Heat Shock Protein 27 Antibody Levels and Diabetes Complications in the EURODIAB Study
por: Burt, Davina, et al.
Publicado: (2009)

Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study
por: Gruden, Gabriella, et al.
Publicado: (2012)

Serum Heat Shock Protein 27 and Diabetes Complications in the EURODIAB Prospective Complications Study : A Novel Circulating Marker for Diabetic Neuropathy
por: Gruden, Gabriella, et al.
Publicado: (2008)

QTc Interval Prolongation Is Independently Associated With Severe Hypoglycemic Attacks in Type 1 Diabetes From the EURODIAB IDDM Complications Study
por: Gruden, Gabriella, et al.
Publicado: (2012)

MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS
por: Barutta, Federica, et al.
Publicado: (2021)

Response to Comment on: Gruden et al. Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2012;35:1598–1604
por: Gruden, Gabriella, et al.
Publicado: (2012)

Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
por: Peeters, Stijn A, et al.
Publicado: (2015)

Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study
por: Engelen, Lian, et al.
Publicado: (2014)

Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
por: Peeters, Stijn A, et al.
Publicado: (2015)

Low 25-hydroxyvitamin D(2) and 25-hydroxyvitamin D(3) levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study
por: Engelen, Lian, et al.
Publicado: (2015)

N-Terminal Probrain Natriuretic Peptide Is a Stronger Predictor of Cardiovascular Mortality Than C-Reactive Protein and Albumin Excretion Rate in Elderly Patients With Type 2 Diabetes: The Casale Monferrato population-based study
por: Bruno, Graziella, et al.
Publicado: (2013)

Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in Europe: The EURODIAB Prospective Complications Study (PCS)
por: Soedamah-Muthu, Sabita S., et al.
Publicado: (2008)

N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes
por: Hamano, Kumiko, et al.
Publicado: (2014)

Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy
por: Barutta, Federica, et al.
Publicado: (2013)

N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes [Corrigendum]
Publicado: (2014)

Heat Shock Proteins in Vascular Diabetic Complications: Review and Future Perspective
por: Bellini, Stefania, et al.
Publicado: (2017)

Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS)
por: Soedamah-Muthu, S. S., et al.
Publicado: (2008)

Low Peripheral Nerve Conduction Velocities and Amplitudes Are Strongly Related to Diabetic Microvascular Complications in Type 1 Diabetes: The EURODIAB Prospective Complications Study
por: Charles, Morten, et al.
Publicado: (2010)

Investigation of optimum N-terminal probrain natriuretic peptide level in patients on maintained hemodialysis
por: Chen, Lan, et al.
Publicado: (2017)

Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
por: Barutta, Federica, et al.
Publicado: (2011)

The Predictive Value of N-Terminal Probrain Natriuretic Peptide for Infection in Patients With Acute Myocardial Infarction
por: Dai, YiNing, et al.
Publicado: (2021)

MicroRNA and Microvascular Complications of Diabetes
por: Barutta, F., et al.
Publicado: (2018)

The diagnostic value of n-terminal probrain natriuretic peptides to differentiate neonatal pneumoniae and transient tachypnea of the newborn
por: ARSLAN, Zeynep, et al.
Publicado: (2023)

The Effect of Age and NT-proBNP on the Association of Central Obesity with 6-Years Cardiovascular Mortality of Middle-Aged and Elderly Diabetic People: The Population-Based Casale Monferrato Study
por: Bruno, Graziella, et al.
Publicado: (2014)

NT-proBNP Linking Low-Moderately Impaired Renal Function and Cardiovascular Mortality in Diabetic Patients: The Population-Based Casale Monferrato Study
por: Bruno, Graziella, et al.
Publicado: (2014)

Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study
por: Schoenaker, D. A. J. M., et al.
Publicado: (2012)

Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
por: Barutta, Federica, et al.
Publicado: (2010)

Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study
por: Soulimane, Soraya, et al.
Publicado: (2022)

Perioperative changes in plasma brain natriuretic peptide and N-terminal probrain natriuretic peptide in patients undergoing coronary bypass surgery under cardiopulmonary bypass
por: Ciufu, M, et al.
Publicado: (2004)

Clinical Characteristics of Patients with Different N-Terminal Probrain Natriuretic Peptide Levels after Hematopoietic Stem Cell Transplantation
por: Se, Zhen, et al.
Publicado: (2020)

Value of Follow-Up N-Terminal Probrain Natriuretic Peptide (NT-proBNP) after a Modified Fontan Procedure
por: Li, Jianbin, et al.
Publicado: (2021)

Circulating N-Terminal Probrain Natriuretic Peptide Levels in Relation to Ischemic Stroke and Its Subtypes: A Mendelian Randomization Study
por: Li, Ming, et al.
Publicado: (2022)

NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study
por: Baldassarre, Stefano, et al.
Publicado: (2017)

Effect of the Monocyte Chemoattractant Protein-1/CC Chemokine Receptor 2 System on Nephrin Expression in Streptozotocin-Treated Mice and Human Cultured Podocytes
por: Tarabra, Elena, et al.
Publicado: (2009)

Serum Cardiac Markers in Patients with Acute Myocardial Infarction: Oxidative Stress, C-Reactive Protein and N-Terminal Probrain Natriuretic Peptide
por: Kasap, Seçil, et al.
Publicado: (2007)

Prognostic Value of N-terminal Probrain Natriuretic Peptide for Patients with Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis
por: Ni, Qi, et al.
Publicado: (2020)

Increased QT Interval Dispersion Predicts 15-Year Cardiovascular Mortality in Type 2 Diabetic Subjects: The population-based Casale Monferrato Study
por: Giunti, Sara, et al.
Publicado: (2012)

Correction to: Chen, Chen, Ling, Lin, He, and Guan, Investigation of optimum N-terminal probrain natriuretic peptide level in patients on maintained hemodialysis
Publicado: (2017)

Metformin and N-terminal pro B-type natriuretic peptide in type 2 diabetes patients, a post-hoc analysis of a randomized controlled trial
por: Top, Wiebe M. C., et al.
Publicado: (2021)

Elevated Level of Troponin but Not N-Terminal Probrain Natriuretic Peptide Is Associated with Increased Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Calculated According to the ESC Guidelines 2014
por: Rajtar-Salwa, Renata, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_noh8m7091ai9c5vgsn6sgtqi97